Jefferson to pay $2.6 million to settle research-fraud case

Article Abstract:

The federal government has reached a $2.6 million civil settlement with Thomas Jefferson University over allegations of fraud in two research projects. The university was alleged to have provided false or fabricated data on its anti-HIV gene therapy and leukemia research in connection with $1.3 million in government funds.

Research and Development in the Physical, Engineering, and Life Sciences, Research and Testing Services, Police Protection, Colleges and universities, Fraud, Cancer & Cell R&D, Cancer research

---

Pa. expects $266 million soon from tobacco deal

Article Abstract:

The state of Pennsylvania will receive its $266 million share of a settlement with the tobacco industry following the refusal of the state Supreme Court to hear a challenge to the tobacco agreement. The state, which will place the money into its general fund, will receive $11.3 billion over 25 years.

Tobacco farms, Tobacco, Tobacco Farming

---

Penn planning new housing at 34th, Chestnut

Article Abstract:

The University of Pennsylvania plans to build a 19 story tower and five story building for student and faculty housing. Space will be allocated for a restaurant, classrooms and retail stores. The project will cost $111 million. It is part of Penn's plan to revitalize the streets around the campus.

Facilities & equipment

Similar abstracts:

• Abstracts: Toy chain to sell 3.75 million shares. Donations spur cancer research
• Abstracts: Japanese firm to buy division of Centocor. European drug firms may merge
• Abstracts: U.S. trade imbalance grows to $46 billion. Smaller spending increase in Feb.
• Abstracts: Ask, nip, tuck. Capital Region home health care agencies. Licensed health plans
• Abstracts: Hollywood agrees to offer from smaller rival. Wachovia agrees to buy competitor SouthTrust

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.